SCHEMBL1603817

SCHEMBL1603817

O=C(O)CCC(=O)CCC(=O)O.O=C(O)CCC(=O)CCC(=O)O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.75
EGLN1 Q9GZT9 4/20 0.75
ALKBH5 Q6P6C2 1/20 0.75
SUCNR1 Q9BXA5 1/20 0.75
ACE P12821 1/20 0.71
GABRR1 P24046 1/20 0.65
KDM4E B2RXH2 3/20 0.58
KDM5C P41229 3/20 0.58
PHF8 Q9UPP1 3/20 0.58
KDM2A Q9Y2K7 3/20 0.58
KDM6B O15054 2/20 0.58
SLC22A6 Q4U2R8 1/20 0.53
SLC15A2 Q16348 1/20 0.53
MAPK1 P28482 1/20 0.53
SLC13A3 Q8WWT9 1/20 0.53
OR51E2 Q9H255 1/20 0.53
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
CYP2C19 P33261 1/20 0.52
TSHR P16473 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25203 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL22464687 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL30203931 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL562396 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
Acetic Acid SCHEMBL9689708 0.89 EGLN1 (0.65) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL23002867 0.87 SLC22A6 (0.69) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL24696 0.87 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL4269135 0.87 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL21867134 0.87 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL3799615 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082264-A1 TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS SEGETIS, INC. (US) 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082264-A1 TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS TKT, KHK, KYAT3 LMNA 1269/4885EGLN1 2059/4885ALKBH5 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.